High-risk additional chromosomal abnormalities at low blast counts herald death by CML
2020 · Leukemia · 86 citations
https://doi.org/10.1038/s41375-020-0826-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
0
Citations
0
h-index
0
i10-index
A. Lindemann is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research.
Click to start Chat